for Sponsors & CROs
research-enabled Visit Centres. Orizzonte combines Central Research Operations,
robust governance and dedicated research capability to support consistent, high-quality study delivery.
For Sponsors & CROs
Your Trials. Our Community Reach.
A Different Approach to Research Delivery
Clinical research delivery continues to evolve alongside healthcare systems, participant expectations, and study requirements. While hospital-based research remains essential for many studies, selected research activities may also be delivered through community healthcare environments. Orizzonte’s infrastructure model extends research delivery into established healthcare settings through research-enabled Visit Centres supported by central operational management and governance frameworks.
What We Offer
Real-World Feasibility
Patient population insights directly from GP systems, ensuring the right patients, right sites, and right conditions.
End-to-End Trial Delivery
In-person, hybrid, and decentralised visit support across primary care settings, fully integrated with sponsor CTMS and EDC systems.
Local Trial Teams
Research-trained GPs, dedicated study coordinators, and experienced research nurses supporting every site.
Decentralised Trial Support
Flexible visit models with options for home visits, virtual appointments, and remote monitoring.
What We Offer
Real-World Feasibility
Patient population insights directly from GP systems, ensuring the right patients, right sites, and right conditions.
End-to-End Trial Delivery
In-person, hybrid, and decentralised visit support across primary care settings, fully integrated with sponsor CTMS and EDC systems.
Local Trial Teams
Research-trained GPs, dedicated study coordinators, and experienced research nurses supporting every site.
Decentralised Trial Support
Flexible visit models with options for home visits, virtual appointments, and remote monitoring.
Accelerated Recruitment
Improved Retention
Increased Diversity & Inclusion
Regulatory Confidence
Operational Efficiency
Why Partner with Orizzonte
Accelerated Recruitment
Improved Retention
Increased Diversity & Inclusion
Regulatory Confidence
Operational Efficiency
Why Partner with Orizzonte?
Orizzonte provides healthcare-integrated research infrastructure designed to support Sponsors and CROs throughout the study lifecycle. Our model combines:
Research-enabled Visit Centres
Central Research Operations
Feasibility and site selection
Participant recruitment
Governance and quality oversight
Multi-site delivery
Visit Centres
Visit Centres integrate clinical research into established primary care. Depending on study requirements, they may support:
Participant recruitment
Study visits
Study assessments
Follow-up appointments
Research coordination
Central Research Operations
Central Research Operations coordinate study delivery across the network. Core functions include:
Study start-up
Site activation
Operational planning
Sponsor communication
Quality oversight
Performance monitoring
Feasibility & Site Selection
Every study is assessed to identify the most appropriate delivery model. Assessments consider:
Protocol requirements
Participant populations
Infrastructure capability
Operational feasibility
Delivery complexity
Governance & Quality
Research delivery is supported by centrally managed governance and quality systems. These frameworks support:
Participant safety
Regulatory compliance
Data integrity
Consistent operational standards
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Feasibility & Site Selection
Study feasibility is assessed against infrastructure capability, participant pathways, operational requirements, and protocol specifications.
This approach helps support:
Appropriate site selection
Delivery readiness
Resource planning
Operational efficiency
Study performance objectives
Why Community-Based Research Delivery Matters
Many individuals access healthcare through GP practices and community services.
Where appropriate, research delivered through these environments may support:
Access to broader participant populations
Integration with existing healthcare pathways
Community-based participation opportunities
Continuity of participant engagement
Governance & Quality
Research delivery operates within established governance, regulatory, and quality frameworks. These frameworks support:
Participant safety
Study compliance
Data integrity
Confidentiality requirements
Operational accountability
Continuous quality improvement
Governance is maintained throughout the study lifecycle to support research integrity and delivery quality.
Working With Orizzonte
Orizzonte works collaboratively with Sponsors and CROs to assess study requirements, delivery pathways, and infrastructure suitability.
The objective is to align each study with the most appropriate research environment while maintaining operational consistency and participant-focused delivery.
Frequently Asked Questions
Suitability depends on study requirements, participant safety considerations, infrastructure needs, and operational feasibility. Each opportunity is assessed individually.
Operational management, governance frameworks, and standardised processes support consistency across multiple Visit Centre locations.
Yes. The infrastructure model is designed to support commercial clinical research delivery alongside other study types where appropriate.
Site selection is informed by feasibility assessment, infrastructure capability, participant pathways, and operational requirements.
Yes. Orizzonte collaborates directly with Sponsors and CROs throughout feasibility, study planning, activation, and delivery.
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Discuss Your Study
Talk to our team about delivering your next study through Orizzonte’s healthcare-integrated research infrastructure.
Latest News & Articles
Artificial Intelligence and the Transformation of Clinical Trials
The Diversity Dilemma: Why Representation in Clinical Trials Is Non-Negotiable
Decentralized Clinical Trials: Redefining Research in a Digitally Connected World
Connect with our leaders
Dr. Zuhaib Keekeebhai
Lead Principal Investigator – Primary Care Trials
Dr Gillian Hood
Diabetes Research Manager at Barts & the London School of Medicine and Dentistry, Queen Mary, University of London
Akash Patel
Consultant Trauma and Orthopaedic Surgeon at RoyalFreeLondonNHSFoundation Trust and Associate professor at University College London
Who we work with
Pharmaceuticals
Hospitals
Academia
Who we work with
Pharmaceuticals
Hospitals
Academia
Why It Matters
Reduced Trial Delays
Evidence-based site selection helps avoid underperforming sites and recruitment shortfalls.
Real-World Representation
Our network includes practices in urban, rural, and underserved regions—ensuring diversity in study populations.
Sponsor Confidence
Data-driven feasibility and operational readiness give sponsors the insight they need for confident site selection.
